🔥 POISE-3 Urology published in European Urology 🚨
In the largest randomized placebo-controlled #urology analysis of #TranexamicAcid (TXA), #TXA reduced major #bleeding risk by 37% (from 9.5% to 6.1%) with no clear increase in #thrombosis
More at https://t.co/Yypy7vb9Jz
#EBM
A hospital policy of tranexamic acid to reduce (RBC) transfusion in major non-cardiac surgery: The TRACTION trial [Dec 9, 2025] Houston et al. #ASH25 LBA-5 https://t.co/nESdY4D5jP #NCT04803747#anemia#hemeonc no increase in #VTE
@BrettLHouston presenting the results of the TRACTION trial as a late-breaking at #ASH25. In 8300 pts undergoing major non cardiac surgery, a policy of tranexamic acid reduces RBC transfusion w/ no difference in VTE at 90 days
@umanitoba@CancerCareMB@CIHR_IRSC@Research_MB
A pleasure to finally share our findings of a large RCT of radical cystectomy patients from 10 Canadian institutions. To our shock, TXA did not reduce transfusion. Thank you to the patients, collaborators, and the many research staff. @WesKassouf@mcisaac_d@CIHR_IRSC
@WesKassouf@AmerUrological@SFreedlandMD@CanUrolAssoc@RSanchez_Salas@ChapinMD@UroOncMD Learning a lot from this trial for sure - congrats to authors and patients! Caveat is that these are high risk patients and no observation until mets arm. In lower risk PSA-recurrent, observation with delayed doublet or triplet Tx (if/when Mets detected) may still be “better”.
Just published: Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications by @LemireFrancis1@RodBreau et al.
https://t.co/XgNGoytlvF
#CUAOnDemand
Network Meta-Analyses (NMA) in Practice
Missed the live webinar? No worries, we have you covered 😀 you can access this session and also complete the quiz for your section 3 credits.
Click here: https://t.co/wIP3lB1RLP
#UROpediaCanada@RodBreau@WallisCJD
On June 23, at the CUA Mtg. in Montreal, Dr. Armen Aprikian announced the re-naming of the CUASF - KCRNC Kidney Cancer Cancer Research Grant as The Anil Kapoor Kidney Cancer Research Grant in memory of his leadership & support of kidney cancer research.
#CUA23@KidneyCancer_Ca
🥾⛺️JOIN US TONIGHT for #1! Clinical Evidence Bootcamp Series!
➡️SIGN up for 1, 2 or all 3! simply select your date & time: https://t.co/rOK2jTpqEh
@winsoncheung@WallisCJD@RodBreau@Astellas
Dr Levitt presenting patient survey data used to inform our post prostatectomy Adj ADT trial. Partnering with patients for an acceptable design (1 yr ADT) with outcomes (avoiding radiation and recurrence) imp to patients @AUA2023@CIHR_IRSC @ProstateCancerC @RSanchez_Salas
High quality guidelines are so important. This is a great way to learn more about how to create and use clinical practice guidelines +/- new pair of cowboy boots